Cargando…
A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma
Aberrant immunity has been associated with the initiation and progression of cancers such as hepatocellular carcinoma (HCC). Here, we aim to develop a signature based on immune-related genes (IRGs) to predict the prognosis of HCC patients. The gene expression profiles of 891 HCC samples were derived...
Autores principales: | Li, Qinghe, Fan, Bin, Ding, Jun, Xiang, Xiaoxi, Zhang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376334/ https://www.ncbi.nlm.nih.gov/pubmed/34414957 http://dx.doi.org/10.1097/MD.0000000000026948 |
Ejemplares similares
-
Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023) -
Prognosis and tumor immune microenvironment of patients with gastric cancer by a novel senescence-related signature
por: Zhang, Guanglin, et al.
Publicado: (2022) -
Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection
por: Zhu, Ying, et al.
Publicado: (2017) -
Evaluating the predictive power of circulating tumor cells for the prognosis of transarterial chemoembolization treatment on patients with advanced hepatocellular carcinoma
por: Deng, Jun, et al.
Publicado: (2021) -
Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma
por: Tu, Jian-Fei, et al.
Publicado: (2016)